GSA Capital Partners’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-41,031
| Closed | -$105K | – | 1837 |
|
|
2024
Q4 | $105K | Sell |
41,031
-66,954
| -62% | -$171K | 0.01% | 1509 |
|
|
2024
Q3 | $402K | Buy |
107,985
+80,318
| +290% | +$299K | 0.03% | 1058 |
|
|
2024
Q2 | $175K | Buy |
+27,667
| New | +$175K | 0.01% | 1477 |
|
|
2023
Q1 | – | Sell |
-22,043
| Closed | -$112K | – | 1678 |
|
|
2022
Q4 | $112K | Buy |
+22,043
| New | +$112K | 0.01% | 1291 |
|
|
2022
Q3 | – | Sell |
-84,884
| Closed | -$316K | – | 1682 |
|
|
2022
Q2 | $316K | Buy |
84,884
+1,680
| +2% | +$6.25K | 0.05% | 789 |
|
|
2022
Q1 | $467K | Sell |
83,204
-46,056
| -36% | -$258K | 0.06% | 583 |
|
|
2021
Q4 | $786K | Buy |
+129,260
| New | +$786K | 0.1% | 323 |
|
|
2020
Q2 | – | Sell |
-13,119
| Closed | -$38K | – | 841 |
|
|
2020
Q1 | $38K | Buy |
+13,119
| New | +$38K | 0.01% | 968 |
|